Creating a Chain Reaction: WCG’s Approach to Trust in Clinical Trial Participation
The post Creating a Chain Reaction: WCG’s Approach to Trust in Clinical Trial Participation appeared first on WCG. Source: Drug Industry Daily
The post Creating a Chain Reaction: WCG’s Approach to Trust in Clinical Trial Participation appeared first on WCG. Source: Drug Industry Daily
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. Source: FDA Press Releases
The FDA is announcing that today, the unified HFP, a new model for field operations and other modernization efforts is now in effect. This is the single largest reorganization in…
Deformities of the spine, in which the spine is abnormally curved or aligned, can often seriously impact mobility, cause debilitating pain and negatively affect a patients overall quality of life.…
This content is password protected. To view it please enter your password below: Password: The post WCG’s 2024 Clinical Research Site Challenges Report appeared first on WCG. Source: Drug Industry…
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. Source: FDA Press Releases
Coverage Analysis for Oncology SlidesDownload The post Coverage Analysis for Oncology Trials: Understanding the Nuances and Keys to Success appeared first on WCG. Source: Drug Industry Daily
In the ever-evolving landscape of clinical research, site feasibility and start-up processes remain critical yet challenging aspects that can significantly impact study timelines, costs, and overall success. In a recent…
FDA approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets…
This guidance is one in a series of guidances that provide recommendations regarding eligibility criteria for clinical trials of investigational drugs or biological products for the treatment of cancer. Specifically,…